CN114031679A - 检测用隐孢子虫卵囊壁外壁标记蛋白质及其应用 - Google Patents

检测用隐孢子虫卵囊壁外壁标记蛋白质及其应用 Download PDF

Info

Publication number
CN114031679A
CN114031679A CN202111323961.2A CN202111323961A CN114031679A CN 114031679 A CN114031679 A CN 114031679A CN 202111323961 A CN202111323961 A CN 202111323961A CN 114031679 A CN114031679 A CN 114031679A
Authority
CN
China
Prior art keywords
ile
leu
ser
lys
asn
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202111323961.2A
Other languages
English (en)
Inventor
朱冠
王东强
尹继刚
武晓东
赵继学
姜鹏
王广
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jilin University
Original Assignee
Jilin University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jilin University filed Critical Jilin University
Priority to CN202111323961.2A priority Critical patent/CN114031679A/zh
Publication of CN114031679A publication Critical patent/CN114031679A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/20Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64Fluorescence; Phosphorescence
    • G01N21/6428Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56905Protozoa
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854Immunoglobulins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64Fluorescence; Phosphorescence
    • G01N21/6428Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
    • G01N2021/6432Quenching
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/44Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from protozoa
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00Immunoassays for the detection of microorganisms
    • G01N2469/10Detection of antigens from microorganism in sample from host

Abstract

本发明公开了一种隐孢子虫卵囊壁蛋白,它的氨基酸序列如序列表SEQ ID N0.1、2、3或4所示;隐孢子虫特异性多肽,氨基序列为:A‑1:C‑ENIEQESNEANI或A‑2:KITGSHKVFRSSFYSR‑或A‑3:C‑SLSVNEYNAEIVDHE或A‑4:C‑NRAYRIDKYVPRGFT;抗隐孢子虫卵囊壁蛋白抗体,它能与隐孢子虫卵囊壁的外表面特异性结合;抗隐孢子虫特异性多肽抗体,它是采用所述的隐孢子虫特异性多肽的蛋白制备的抗体;在检测隐孢子虫的应用。本发明蛋白抗体均证明该蛋白是隐孢子虫卵囊壁外壁蛋白,且荧光信号较强;多肽抗体滴度高,检测效果好,不发生交叉反应,特异性良好。

Description

检测用隐孢子虫卵囊壁外壁标记蛋白质及其应用
技术领域
本发明属于生物学检测技术领域,具体涉及检测用隐孢子虫卵囊壁外壁标记蛋白质及其应用。
背景技术
隐孢子虫为寄生原虫顶复门(Apicomplexa)下的一个属,包括多个感染人或动物的物种。其中人兽共患的“微小隐孢子虫”(Cryptosporidium parvum)和人体特异的“人隐孢子虫”(Cryptosporidium hominis)是全球范围内造成由隐孢子虫病引起的严重、甚至致死的腹泻的两个主要病原;而微小隐孢子虫亦可感染包括牛、山羊和绵羊等多个经济动物,可造成其幼崽严重腹泻及死亡。隐孢子虫为胃肠道寄生虫,主要通过粪-口途径传播,宿主因摄取被隐孢子虫污染的水或食品等后被感染。其主要寄生于小肠上皮细胞,对宿主造成的症状轻重不一,主要表现为中度至重度腹泻。在免疫功能正常的人群和动物中,隐孢子虫病一般为自限性;但是在免疫力低下的宿主中(如艾滋病患者),是主要的致死原因。隐孢子虫卵囊呈圆形或椭圆形,显微尺寸(如微小隐孢子虫卵囊直径约5微米),主要结构包括卵囊壁和其包裹的4个子孢子,可以在环境中长期存活(图1)。卵囊壁结构特异,可抵抗常规的次氯酸钠消毒,因此隐孢子虫是控制食品(如蔬菜、莓果等)和水样(如饮用水、娱乐用水等)中微小隐孢子虫污染的一大难题。迄今为止尚无针对微小隐孢子虫的特效药物和疫苗,这进一步加大了对微小隐孢子虫防治工作的需求。目前,针对环境中人或动物临床样本中的微小隐孢子虫检测方法主要包括病原学检测,分子生物学检测和免疫学检测卵囊或虫体抗原。其中病原检测可通过显微镜直接观察未染色或标记的卵囊,但该方法费时费力,灵敏度极低,需熟练的技术员操作;现有的分子生物学诊断灵敏度和特异性较高,但对检测仪器要求较高;而免疫学检测方法具有一定的灵敏度和特异性,适用于临床检查和环境样本监测,但需要拥有可特异性标记卵囊外壁的抗体。此外,环境中的虫体卵囊含量通常被高度稀释,部分临床样本的卵囊含量较低,针对这类样本的检测需在使用上述诊断方法前进行卵囊的富集和浓缩(非特异的物理方法:仅通过离心沉淀;通过高密度液体漂浮、结合离心沉淀;特异的免疫学方法:使用偶链了可标记隐孢子虫卵囊外壁的抗体的小颗粒或小磁珠捕获卵囊,再通过离心沉淀或磁性物体沉淀收集颗粒或磁珠)。
目前国内的隐孢子虫的临床检测方法主要靠抗酸染色等方法进行检测卵囊,该方法特异性低,敏感性差。而目前国外有一种荧光抗体标记隐孢子虫卵囊壁的诊断试剂盒,其利用一个具体基因信息不详的卵囊壁蛋白为抗原(仅一个蛋白质)制作的抗体荧光标记卵囊壁,用于显微镜观察检测。该抗体也被用于样本中隐孢子虫卵囊的免疫学富集。基于该抗体的检测试剂盒价格昂贵,不易大规模利用。且国内利用间接免疫荧光(IFA)检测环境水样或临床样本中隐孢子虫的方法处于空白,主要原因是目前领域内仍未发现可用于研发标记卵囊外壁的特异性抗体的、位于隐孢子虫卵囊壁外壁的蛋白质。因此,寻找隐孢子虫卵囊壁外壁的标记蛋白质,据此制备抗卵囊外壁的特异抗体,并建立相关免疫学检测方法和样本富集方法,对水样中隐孢子虫的监测、临床隐孢子虫病的检测和诊断、人与动物隐孢子虫感染的流行病调查、以及人兽共患隐孢子虫的防治研究等具有非常重要的意义。
发明内容
本发明目的是提供检测用隐孢子虫卵囊壁外壁标记蛋白质及其应用。
隐孢子虫卵囊壁蛋白,它的氨基酸序列如序列表SEQ ID N0.1、2、3或4所示;
所述的隐孢子虫卵囊壁蛋白,位于隐孢子虫卵囊壁外壁的外表面。
隐孢子虫特异性多肽,它的氨基序列为:
A-1:C-ENIEQESNEANI
或A-2:KITGSHKVFRSSFYSR-C
或A-3:C-SLSVNEYNAEIVDHE
或A-4:C-NRAYRIDKYVPRGFT;
抗隐孢子虫卵囊壁蛋白抗体,它能与隐孢子虫卵囊壁的外表面特异性结合,所述的隐孢子虫卵囊壁蛋白为所述的隐孢子虫卵囊壁蛋白。
抗隐孢子虫特异性多肽抗体,它是采用所述的隐孢子虫特异性多肽的蛋白制备的抗体。
抗隐孢子虫卵囊壁蛋白抗体或抗隐孢子虫特异性多肽抗体在检测隐孢子虫的应用;
所述的检测隐孢子虫为检测未破壁的隐孢子虫卵囊。
本发明提供了隐孢子虫卵囊壁蛋白,它的氨基酸序列如序列表SEQ ID N0.1、2、3或4所示;所述的隐孢子虫卵囊壁蛋白,位于隐孢子虫卵囊壁外壁的外表面。隐孢子虫特异性多肽,它的氨基序列为:A-1:C-ENIEQESNEANI或A-2:KITGSHKVFRSSFYSR-C或A-3:C-SLSVNEYNAEIVDHE或A-4:C-NRAYRIDKYVPRGFT;抗隐孢子虫卵囊壁蛋白抗体,它能与隐孢子虫卵囊壁的外表面特异性结合,所述的隐孢子虫卵囊壁蛋白为所述的隐孢子虫卵囊壁蛋白。抗隐孢子虫特异性多肽抗体,它是采用所述的隐孢子虫特异性多肽的蛋白制备的抗体。抗隐孢子虫卵囊壁蛋白抗体或抗隐孢子虫特异性多肽抗体在检测隐孢子虫的应用;所述的检测隐孢子虫为检测未破壁的隐孢子虫卵囊。本发明蛋白抗体均证明该蛋白是隐孢子虫卵囊壁外壁蛋白,且荧光信号较强;多肽抗体滴度高,检测效果好,不发生交叉反应,特异性良好。
附图说明
图1 隐孢子虫主要结构示意图;
图2为3种重组蛋白证明该蛋白为卵囊壁外壁蛋白;
图3 为4种多肽多克隆抗体效价检测图;
图4 A1多肽抗体通过间接免疫荧光(IFA)证明该蛋白为卵囊壁外壁蛋白;
图5 A1多肽抗体不同滴度检测灵敏度;
图6 不同样本特异性检测图。
具体实施方式
实施例1微小隐孢子虫cgd3_4170蛋白质重组蛋白质的筛选
1、在隐孢子虫的专业网站(http://cryptodb.org/cryptodb/)搜索基因号cgd3_4170,下载其氨基酸序列,序列如SEQ ID N0.1所示;
2、构建原核表达载体
将该蛋白质的氨基酸分成3部分,分别为:N51-C498序列如SEQ ID N0.2所示;N493-C813序列如SEQ ID N0.3所示,N807-C1289序列如SEQ ID N0.4所示(N,C分别表示蛋白质的N端与C端),分别连接在表达载体pET-28a 上,表达重组蛋白质。
实施例2 三段重组蛋白的表达及纯化
1、表达条件的筛选与优化
将成功连接pET-28a载体(His标签)上的菌株划线,挑单菌落于5 mL液体培养基中培养8-10小时。然后将菌液按1:100扩大培养2小时左右,测600 nm的OD值达到0.6左右时,进行诱导表达。加入终浓度为0.1 mmol/ L 的IPTG(异丙基硫代半乳糖苷)进行诱导,设定三个不同的诱导温度与时长,分别为16℃,12 h;25℃,6 h;37℃,3 h。同时设立不加IPTG的对照组,确定最佳表达条件。
2、His标签重组蛋白质的纯化
1)选择适当的诱导条件诱导蛋白表达之后,收集菌液,4℃,3500 r/min离心10min后,弃掉上清;
2)加入适量的PBS缓冲液充分悬浮沉淀;
3)用20 mL 5 mM的咪唑溶液将沉淀涡旋混匀,加入PMSF(0.5 mmol/L)和TritonX-100(1%)混匀后将离心管置于冰水混合物中,用超声破碎仪将菌体破碎,设定超声参数:工作时间15 min,超声3 s,停止3 s,功率为160 W;
4)将超声后的液体16400 rpm/min,4℃离心30 min,收集上清液;
5)利用His GraviTrapTM柱子纯化重组蛋白质,待镍柱内的20%乙醇流完之后加入20 mL 5 mM的咪唑溶液平衡柱子。5 mM咪唑流完之后缓慢加入上述裂解菌体上清,孵育2小时左右,然后使其缓慢流经镍柱。随后依次加入20 mM、40 mM、60 mM、80 mM、100 mM咪唑进行洗杂。最后加入500 mM咪唑1 mL,孵育10 min,收集流出液,重复3次。整个过程在4℃进行;
6)将PBS预冷,透析蛋白以去咪唑,透析时间不应少于1 h。透析后测定蛋白浓度,并用SDS-PAGE和Western blot对这3段重组蛋白质进行鉴定。
实施例3 重组蛋白动物免疫及抗体的制备及间接免疫荧光检测
一、实验动物免疫程序
3段重组蛋白免疫新西兰大白兔。首次免疫取300ug/只(重组蛋白)与弗氏完全佐剂等体积乳化,皮内多点注射。首免两周后,取重组蛋白 (150μg/只)与弗氏不完全佐剂等体积混合乳化后加强免疫,共四次。首次免疫前和第四次免疫后14天的血清,采自耳缘静脉血,分离血清,用于后续检测。
二、间接免疫荧光检测
对于环境或临床样本,利用饱和食盐水漂浮或蔗糖漂浮的方法,除去大部分细菌及杂质在进行后续试验,然后按以下步骤进行操作;
(1)处理盖玻片:将盖玻片用0.1 mg/mL的多聚赖氨酸处理30 min,ddH2O漂洗一次,室温2 小时风干。
(2)固定样本:将完整卵囊用4%多聚甲醛室温固定30 min,用PBS洗去多余的甲醛。
(3)画圈涂样:用组化笔在已处理盖玻片中央画一小圈,取30 μL子孢子滴在小圈内,室温放置1 小时;
(4)清洗:吸去盖玻片上的液体,用PBS洗3-4次,5 min/次;
(5)一抗:用含3% BSA 的PBS将抗血清1∶50稀释后取50 μL加入盖玻片上,室温孵育 1小时或者4℃ 过夜。(注:对于卵囊壁外壁蛋白的验证:抗体孵育15 分钟,且对样本不做透化处理,能染上荧光,则证明该蛋白为卵囊壁外壁蛋白,如图1)。
(6)二抗:PBS洗涤后,每孔中加入Alexa Fluor® 488 goat anti-rabbit IgG (1∶1 000),37 ℃避光1 h。
(7)染核:PBS洗涤,每孔加入终浓度为1 µg/mL的DAPI(4',6-二脒基-2-苯基吲哚),室温避光染核5 min,PBS洗3-4次。
(8)封片:滴一滴抗荧光淬灭剂,用封片液封片后荧光显微镜下观察。
结果如图1所示,上述3组重组蛋白抗体均证明该蛋白是隐孢子虫卵囊壁外壁蛋白,且荧光信号较强,说明该蛋白具有潜在的建立价值。为了更加确切证实其是卵囊壁外壁蛋白以及最大效果的提高检测的灵敏度与特异性,我们对其设计了4段特异性良好的多肽序列进一步佐证。
实施例4 微小隐孢子虫cgd3_4170特异性多肽的筛选
(1)在隐孢子虫的专业网站(http://cryptodb.org/cryptodb/)搜索基因号cgd3_4170,下载其氨基酸序列;
(2)特异性多肽的设计
针对特异性多肽的筛选:将所下载的该基因的氨基酸序列输入网址swissmodel.expasy.org中,预测其空间结构,寻找位于Loop区的10-14个氨基酸的多肽片段。然后利用iedb.org网址,分析其B细胞表位,选择预测值较高的片段。最后利用NCBI进行特异性比对分析,选择特异性较强的片段进行合成。
(3)为了增强多肽与KLH和BSA的偶联效率,在设计多肽的时,有选择的避开含有半胱氨酸的多肽,并在N端或C端没有半胱氨酸的多肽后面人工加上一个半胱氨酸。所设计的多肽序列如表1所示:
Figure 49038DEST_PATH_IMAGE001
实施例5 动物免疫及多克隆抗体的制备及效价测定
一、实验动物免疫程序
多肽偶联成功的peptide-KLH免疫新西兰大白兔。首次免疫取偶联好的多肽(300μg/只)与弗氏完全佐剂等体积乳化,皮内多点注射。两周后将peptide-KLH (150μg/只)与弗氏不完全佐剂等体积混合乳化后作为加强免疫,共四次。首次免疫前和第四次免疫后14天的血清,采自耳缘静脉血,分离血清,用于抗体效价的检测。
二、间接ELISA方法检测血清抗体效价
以偶联的BSA多肽为包被抗原,免疫前的血清作为阴性对照,4次免疫后的血清为一抗,碱性磷酸酶(AP)标记的山羊抗兔IgG (H+L)作为二抗,进行间接ELISA检测。包被抗原终浓度为5μg/mL,血清从1:500开始作倍比稀释用,二抗按1:20000稀释,加入显色液,用酶标仪检测A405值。
(1)包被抗原:用Coating Buffer(pH为9.6的0.05 M碳酸盐缓冲液)稀释已经偶联成功的peptide-BSA 5 µg/mL, 50 µL/每孔,37℃,1小时后,4℃过夜;或者37℃两小时便可进行下一步。
(2)洗板:利用Washing Buffer(0.05% Tween-20,8g NaCl/L )洗板,利用ELISA洗板机洗板3-4次,每次间隔4 min。
(3)封闭:加入Blocking Buffer(3% BSA 于pH为9.6的0.05 M碳酸盐缓冲液中)100 µL/每孔,37℃孵育1 h。
(4)洗板:同(2)步骤。
(5)孵一抗:使用Tween Buffer(含0.5% BSA和0.05% Tween-20的PBS溶液)稀释抗体,以首次免疫前的血清作为阴性对照,最后一次免疫后的血清作为阳性抗体,免疫前血清作为阴性对照,按1:500,1:1000,1:2000,1:4000,1:8000,1:16000稀释倍数稀释抗体,每孔50 µL,37℃孵育1 h。
(6)洗板:同(2)
(7) 孵酶标二抗:使用Tween Buffer,1:20000稀释碱性磷酸酶标记的山羊抗兔IgG (H+L)作为二抗, 50 µL/每孔,37℃孵育1 h。
(8)洗板:同(2)
(9) 显色:利用显色液buffer配制1 mg/mL的显色液(PNPP底物显色),50 µL/每孔,37℃避光显色10-20 min,然后利用酶标仪检测A405读值,以偶联BSA的多肽作为检测包被抗原,以ELISA方法检测使用KLH-多肽免疫的兔血清抗体效价。
结果如图2所示,4只家兔四次免疫后,血清有效滴度达1:32,000,其中A-1多肽抗体滴度高,检测效果更好,所以后续检测均用A-1多肽抗血清。
实施例6 免疫电镜标记验证实验
利用A-1多肽进行免疫电镜标记,进一步验证其为卵囊壁外壁蛋白。
一、电镜样品的制备
(1)脱囊:隐孢子虫卵囊于脱囊液(不完全培养基中含0.75%牛胆酸钠盐),37℃ 孵育1h。
(2)固定:4%多聚甲醛-0.1 %戊二醛室温固定2 h,马来酸盐缓冲液(含0.5 mM 马来酸盐)清洗三次,每次30 min。
(3) 块染:将样品与含有0.5 %的醋酸双氧铀的马来酸盐缓冲液在20℃孵育30min,马来酸盐缓冲液清洗三次每次15 min。
(4)凝集:在50 ℃水浴锅中,将固定后的寄生虫用完全溶解的2 %低熔点琼脂糖吹打均匀,室温放置30 min待其充分凝固后,切成~0.5 mm3的小块。
二、样品的脱水及浸透
(1)乙醇梯度脱水:30 %酒精4 ℃脱水30 min;50%酒精4 ℃脱水1 h;70%,80%,90%酒精-20 ℃脱水各1 h;两次100%酒精1 h。
(2)预浸透:无水乙醇:LR-White(2:1)-20℃浸透1 h;无水乙醇:LR-White(1:1)-20℃浸透1 h;无水乙醇:LR-White(1:2)-20℃浸透1 h。
(3)浸透:样品在LR-White中-20℃浸透过夜;样品在LR-White中-20℃浸透24 h;样品在LR-White中-20℃浸透12 h。
(4)聚合:使用 LR-White包埋样品,将样品置于明胶胶囊中,加满LR-White,-15℃紫外聚合24 h。
三、免疫标记
(1)定位及超薄切片:半薄切片1.5 µm厚,选择寄生虫丰富的地方进行超薄切片,超薄切片厚度80 nm,用涂有芳华膜的铜网捞取切片,电镜检查合格后,用涂有芳华膜的镍网捞取切片用于后续金标。
(2)封闭:将镍网倒扣于含有5 %脱脂奶,0.01 % TWEEN 20的PBS上(PBS-MT),室温孵育1 h。
(3)一抗:将抗体稀释于PBS-MT中,4℃过夜,PBS清洗2 min×8次。
(4)二抗:将Goat anti-Rabbit IgG(10 nm Gold)1:50稀释于PBS-MT中,37 ℃ 孵育1 h,PBS清洗1 min×4次,去离子水清洗1 min×4次。
(5)后固定:2%戊二醛四度固定10 min,去离子水清洗1 min×4次。
(6)染色:将镍网插入2 %醋酸双氧铀中染色15 min,去离子水清洗2 min×8次。
实施例6 间接免疫荧光检测样本
对于环境或临床样本,利用饱和食盐水漂浮或蔗糖漂浮的方法,除去大部分细菌及杂质在进行后续试验,然后按以下步骤进行操作;
(1)处理盖玻片:将盖玻片用0.1 mg/mL的多聚赖氨酸处理30 min,ddH2O漂洗一次,室温2 小时风干。
(2)固定样本:将完整卵囊用4%多聚甲醛室温固定30 min,用PBS洗去多余的甲醛。
(3)画圈涂样:用组化笔在已处理盖玻片中央画一小圈,取30 μL子孢子滴在小圈内,室温放置1 小时;
(4)清洗:吸去盖玻片上的液体,用PBS洗3-4次,5 min/次;
(5)一抗:用含3% BSA(牛血清白蛋白) 的PBS将1μL抗A-1多肽血清1∶50稀释后,取50 μL加入盖玻片上,室温孵育 1小时或者4℃ 过夜。(注:对于卵囊壁外壁蛋白的验证:抗体孵育15 分钟,且对样本不做透化处理,能染上荧光,则证明该蛋白为卵囊壁外壁蛋白,如图1)。
(6)二抗:PBS洗涤后,每孔中加入Alexa Fluor® 488 goat anti-rabbit IgG (1∶1 000),37 ℃避光1 h。
(7)染核:PBS洗涤,每孔加入终浓度为1 µg/mL的DAPI(4',6-二脒基-2-苯基吲哚),室温避光染核5 min,PBS洗3-4次。
(8)封片:滴一滴抗荧光淬灭剂,用封片液封片后荧光显微镜下观察。
结果:如图3所示,多肽A1抗体能够灵敏特异的识别隐孢子虫卵囊壁,且利用A1多肽兔血清抗体具有良好的敏感性,如图4所示,当血清 1:100稀释时荧光强度很亮,随着抗体不断稀释,荧光强度逐渐减弱,当血清稀释比列为 1:10000 时还有微弱的荧光,该实验表明血清抗体灵敏度效果非常好。
环境中样本的检测中,A1多肽抗体只识别隐孢子虫卵囊(微小隐孢子虫和泰泽隐孢子虫),不与其他物种(大肠杆菌,球虫,贾滴虫)发生交叉反应,说明抗体特异性良好。
因此选择该卵囊壁外壁蛋白作为候选抗原,作为诊断试剂检测环境水样或临床样本中隐孢子虫的检测潜力巨大。
序列表
<110> 吉林大学
<120> 检测用隐孢子虫卵囊壁外壁标记蛋白质及其应用
<160> 4
<170> SIPOSequenceListing 1.0
<210> 1
<211> 1289
<212> PRT
<213> 微小隐孢子虫(Cryptosporidium parvum)
<400> 1
Met Phe Ile Ser Leu Lys Phe Leu Phe Leu Phe Gly Leu Val Tyr Leu
1 5 10 15
Leu Ser Leu Asn Phe Asn Tyr Tyr Asn Ser Glu Asn Cys Val Lys Ser
20 25 30
Phe Ser Phe Ser Ser Gln Ala His Asn Tyr Asp Ser Lys Ser Pro His
35 40 45
Ile Lys Ser Val Ile Asp Asp Asp Lys Phe Ile Lys Ser Arg Val Asp
50 55 60
Lys Ala Lys Tyr Arg Tyr Ile Lys Leu Lys Asn Gly Leu Lys Ala Phe
65 70 75 80
Leu Val Ser Lys Glu Asp Ala Glu Lys Ser Glu Val Ala Ile Leu Val
85 90 95
Asp Val Gly Phe Leu Tyr Asp Pro Pro Lys Ile Ile Gly Leu Ser Asn
100 105 110
Leu Val Gln Tyr Ser Leu Leu Leu Ala Ser Tyr Gln Tyr Pro Asn Ile
115 120 125
Asn Glu Phe His Asn Phe Ile Lys Leu Leu Asn Gly Arg Met Tyr Leu
130 135 140
Asp Leu His Glu Lys Ser Thr Val Tyr Ser Phe Thr Ile Gly Thr Glu
145 150 155 160
Tyr Leu Ser Glu Ser Ile Phe Arg Phe Ser Ser Tyr Phe His Ser Pro
165 170 175
Leu Leu Asn Asn Asp Thr Ile Asn Lys Ala Met Leu Thr Ile Phe Ser
180 185 190
Gln Leu Asn Arg Met Lys Arg Asn Glu Phe Trp Ala Lys Arg Glu Ile
195 200 205
Glu Arg Glu Ile Ile Gly Leu Asn Ala Lys Phe Asp Thr Phe Tyr Tyr
210 215 220
Gly Asn Lys Asn Thr Leu Leu Asn Asn Pro His Leu Ser Glu Gly Glu
225 230 235 240
Ile Tyr Glu Lys Val Arg His Tyr Phe Ser Lys Phe Tyr Ser Pro Asn
245 250 255
Asn Met Lys Leu Ala Ile Val Gly Arg Glu Pro Leu Asp Lys Leu Glu
260 265 270
Lys Tyr Val Ile Gln Asn Phe Ala His Ile Lys Ser Asn Gly Phe Asn
275 280 285
Ile Val Arg Ile Asp Asp Ser Tyr Lys Tyr Ile Val Asn Pro Phe Ile
290 295 300
Arg Ile Ser Lys Asn Ile Val Thr Ile Arg Arg Phe Lys Lys Thr Gly
305 310 315 320
Ile Asn Thr Ile Asn Leu Arg Phe Pro Ile Glu Ile Gln Val Val Asn
325 330 335
Trp Lys Arg Ile Pro Thr Met Tyr Ile Lys Tyr Leu Leu Asp Gly Asn
340 345 350
Tyr Lys Gly Ile Leu Arg Lys Tyr Leu Lys Ser Ile Gly Ile Ser Asn
355 360 365
Pro Ile Lys Val Gly Val Val Asn Tyr Glu Gly Phe Ser Thr Leu Asp
370 375 380
Ile Ser Ile Asp Leu Tyr Asn Ser Gln Leu Arg His Ser Trp Asn Leu
385 390 395 400
Val Lys Ala Val Ile Ser Ala Val Lys Tyr Ile Ile Glu Leu Pro Val
405 410 415
Ser Glu Arg Ile Val Glu Glu Ala Lys Asn Val Ala Asp Ile Ile Phe
420 425 430
Asn Tyr Arg Glu Thr Glu Phe Thr Arg Asp Leu Ala Tyr Asn Ile Val
435 440 445
Tyr Lys Ala Ser Lys Tyr Arg Ile Lys Pro Gln Glu Ile Ile Tyr Ala
450 455 460
Asp Glu Val Met Glu Ile Val Asp Ile Ser Phe Ile Lys Ala Phe Ile
465 470 475 480
Ser Ser Ile Lys Ile Asp Gln Val Ser Ile Phe Phe Phe Thr Pro Val
485 490 495
Leu Leu Ile Lys Lys Ile Thr Gly Ser His Lys Val Phe Arg Ser Ser
500 505 510
Phe Tyr Ser Arg Gly Phe Asn Val Leu Asn Ser Asn Val Thr Pro Ala
515 520 525
Gly Ile Glu Ser Pro Lys Asn Asn Lys Arg Asp Val Thr Gln Ile Ile
530 535 540
Leu Trp Val Tyr Asn Thr Ile Lys Gln Tyr Leu Ile Lys Ile Leu Thr
545 550 555 560
Phe Ile Phe Gln Lys Glu Leu Gln Thr Glu Asp Thr Ser Ile Lys Lys
565 570 575
Asp Ile Gly Lys Gly Asn Ser Asp Gln Glu Ser Asp Glu Ile Asn Lys
580 585 590
Glu Asn Ser Phe Val Glu Cys Asn Met Val Tyr Lys Ser Lys Asn Leu
595 600 605
Leu Thr Asp Tyr Cys Val Asn Arg Phe Pro Ser Glu Phe Phe Glu Asp
610 615 620
Ile Tyr Asn Leu Ser Leu Ser Ala Ile Lys Ser Thr Tyr Asn Leu Asp
625 630 635 640
Ile Ser Thr Leu Asn Pro Tyr Thr Pro Phe Asp Leu Ser Leu Arg Pro
645 650 655
Ser Asp Glu Asp Thr Lys Ile Val Pro Gln Pro Leu Ile Leu Ser Ile
660 665 670
Lys Arg Phe Met Asn Lys Asn Ile Arg Ser Phe Asn Ser Met Glu Asn
675 680 685
Asp Ile Ile Asn Lys Tyr Asn Phe Trp Tyr Glu Ser Asp Ala Ser His
690 695 700
Tyr Ser Asp Leu Asn Gln Lys Gly Ala Leu Ile Asn Lys Leu Tyr Asn
705 710 715 720
Asn Ser Glu Leu Ala Lys Ser Ile Tyr Gln Asn Leu Thr Asp Ile Glu
725 730 735
Thr Thr His Ser Asn Asp Met Leu Lys Asn Ile Val Gly Glu Asn Ile
740 745 750
Glu Gln Glu Ser Asn Glu Ala Asn Ile Lys Arg Phe Asp Phe Tyr Ser
755 760 765
Asn Ile Val Tyr Phe Tyr Tyr Lys Asn Ser Val Lys Gln Ser Tyr Pro
770 775 780
Glu Val Ser Ile Leu Ile Arg Ile Leu Thr Pro Asn Ile Asn Ser Lys
785 790 795 800
Ile Gly Arg His Pro Lys Val Leu Lys Val Leu Pro Arg Leu Val Val
805 810 815
Ala Ile Glu Ile Leu Cys Val Leu Leu Asn Asn Ser Leu Glu Asp Glu
820 825 830
Ile Tyr Asp Phe Arg Ile Ala Arg Asn Glu Phe Lys Ile Ser Ser Phe
835 840 845
Asn Asp Tyr Thr Tyr Asn Gly Leu Pro Asn Gly Phe Glu Ile His Leu
850 855 860
Lys Gly Phe His Asp Val Leu Pro Lys Phe Leu Arg Ile Phe Ala Lys
865 870 875 880
His Leu Ser His Pro Asn Lys Tyr Phe Thr Leu Glu Gln Phe Glu Asp
885 890 895
Ala Phe Lys His Val Asn Arg Tyr Leu Tyr Gln Tyr Val Tyr Phe Thr
900 905 910
Pro Ser Ile Ile Lys Ser Leu Thr Ile Leu Arg Ser Val Thr Glu Asn
915 920 925
Gln Ser Leu Ser Pro Phe Asp Arg Leu Asn Glu Leu Lys Tyr Ile Ser
930 935 940
Tyr Arg Asp Ile Ile Glu Leu Ser Glu Phe Phe Ala Lys Gln Gly Gln
945 950 955 960
Val Glu Gly Leu Phe Met Asn Asn Ile Asp Pro Phe Glu Ala Gly Leu
965 970 975
Val Val Asn Glu Phe Leu Asp Cys Leu Gly Arg Asn Ile Ile Ile Ser
980 985 990
Gly Ile Ile Ser Leu Ser Val Asn Glu Tyr Asn Ala Glu Ile Val Asp
995 1000 1005
His Glu Leu Leu Lys Asn Ala Phe Arg Lys Glu Ser Lys Glu Tyr Ser
1010 1015 1020
Ile Lys Asn Met Leu Val Pro Ile Tyr His Ala Gly Glu Asn Tyr Phe
1025 1030 1035 1040
Asn Ser Tyr Glu Val Leu Asp Leu Thr Thr Leu Pro Ile Arg Leu Trp
1045 1050 1055
Lys Ser Tyr Arg Phe Glu Tyr Ser Ser Ile Asp Glu Glu Lys Ser Ile
1060 1065 1070
Ser Ser Leu Ala Leu Phe Ile Gly Thr Lys Thr Pro Phe Thr Ile Ser
1075 1080 1085
Leu Val Thr Leu Leu Ser Ile Ile Leu Ser Asp Leu Ala Ser Lys Phe
1090 1095 1100
Leu Lys Lys Ile Ser Asn Lys Asn Tyr Ser Val Val Val Phe Ser Thr
1105 1110 1115 1120
Ser Tyr Tyr Ser Thr Leu Thr Phe Ser Val Val Gln Val Glu Ser Tyr
1125 1130 1135
Ser Lys Asp Ile Val Ser Leu Ser Glu Phe Leu Ile Val Phe Ile Lys
1140 1145 1150
Glu Ile Phe Glu Thr Pro Phe Ile Ile Asp Lys Ser Phe Phe Tyr Lys
1155 1160 1165
Val Lys Arg Asp Cys Ile Asn Lys Phe Lys Asn Leu Pro Asn Lys Ile
1170 1175 1180
Glu Leu Phe Ser Asn Leu Phe Phe Thr Phe Ile Glu Gly Thr Asp Phe
1185 1190 1195 1200
Pro Phe Gln Trp Ile Glu Lys Val Ile His Thr Leu Glu Asn Phe Ser
1205 1210 1215
Tyr Asp Arg Phe Ile Lys Ser Ile Lys Phe Leu Asn Lys Ala Pro Gln
1220 1225 1230
Ile Met Ile Ala Ile Gln Ser Lys Ala Ser Asn Arg Ala Tyr Arg Ile
1235 1240 1245
Asp Lys Tyr Val Pro Arg Gly Phe Thr Met Leu Asn Ser Thr Asp Asp
1250 1255 1260
Leu Leu Asn Gln Asp Asn Leu Ser Ile Tyr Lys Leu Pro Ile Ala Ile
1265 1270 1275 1280
Ser Arg Asn Ile Leu Ser Gln Glu Phe
1285
<210> 2
<211> 448
<212> PRT
<213> 微小隐孢子虫(Cryptosporidium parvum)
<400> 2
Ser Val Ile Asp Asp Asp Lys Phe Ile Lys Ser Arg Val Asp Lys Ala
1 5 10 15
Lys Tyr Arg Tyr Ile Lys Leu Lys Asn Gly Leu Lys Ala Phe Leu Val
20 25 30
Ser Lys Glu Asp Ala Glu Lys Ser Glu Val Ala Ile Leu Val Asp Val
35 40 45
Gly Phe Leu Tyr Asp Pro Pro Lys Ile Ile Gly Leu Ser Asn Leu Val
50 55 60
Gln Tyr Ser Leu Leu Leu Ala Ser Tyr Gln Tyr Pro Asn Ile Asn Glu
65 70 75 80
Phe His Asn Phe Ile Lys Leu Leu Asn Gly Arg Met Tyr Leu Asp Leu
85 90 95
His Glu Lys Ser Thr Val Tyr Ser Phe Thr Ile Gly Thr Glu Tyr Leu
100 105 110
Ser Glu Ser Ile Phe Arg Phe Ser Ser Tyr Phe His Ser Pro Leu Leu
115 120 125
Asn Asn Asp Thr Ile Asn Lys Ala Met Leu Thr Ile Phe Ser Gln Leu
130 135 140
Asn Arg Met Lys Arg Asn Glu Phe Trp Ala Lys Arg Glu Ile Glu Arg
145 150 155 160
Glu Ile Ile Gly Leu Asn Ala Lys Phe Asp Thr Phe Tyr Tyr Gly Asn
165 170 175
Lys Asn Thr Leu Leu Asn Asn Pro His Leu Ser Glu Gly Glu Ile Tyr
180 185 190
Glu Lys Val Arg His Tyr Phe Ser Lys Phe Tyr Ser Pro Asn Asn Met
195 200 205
Lys Leu Ala Ile Val Gly Arg Glu Pro Leu Asp Lys Leu Glu Lys Tyr
210 215 220
Val Ile Gln Asn Phe Ala His Ile Lys Ser Asn Gly Phe Asn Ile Val
225 230 235 240
Arg Ile Asp Asp Ser Tyr Lys Tyr Ile Val Asn Pro Phe Ile Arg Ile
245 250 255
Ser Lys Asn Ile Val Thr Ile Arg Arg Phe Lys Lys Thr Gly Ile Asn
260 265 270
Thr Ile Asn Leu Arg Phe Pro Ile Glu Ile Gln Val Val Asn Trp Lys
275 280 285
Arg Ile Pro Thr Met Tyr Ile Lys Tyr Leu Leu Asp Gly Asn Tyr Lys
290 295 300
Gly Ile Leu Arg Lys Tyr Leu Lys Ser Ile Gly Ile Ser Asn Pro Ile
305 310 315 320
Lys Val Gly Val Val Asn Tyr Glu Gly Phe Ser Thr Leu Asp Ile Ser
325 330 335
Ile Asp Leu Tyr Asn Ser Gln Leu Arg His Ser Trp Asn Leu Val Lys
340 345 350
Ala Val Ile Ser Ala Val Lys Tyr Ile Ile Glu Leu Pro Val Ser Glu
355 360 365
Arg Ile Val Glu Glu Ala Lys Asn Val Ala Asp Ile Ile Phe Asn Tyr
370 375 380
Arg Glu Thr Glu Phe Thr Arg Asp Leu Ala Tyr Asn Ile Val Tyr Lys
385 390 395 400
Ala Ser Lys Tyr Arg Ile Lys Pro Gln Glu Ile Ile Tyr Ala Asp Glu
405 410 415
Val Met Glu Ile Val Asp Ile Ser Phe Ile Lys Ala Phe Ile Ser Ser
420 425 430
Ile Lys Ile Asp Gln Val Ser Ile Phe Phe Phe Thr Pro Val Leu Leu
435 440 445
<210> 3
<211> 321
<212> PRT
<213> 微小隐孢子虫(Cryptosporidium parvum)
<400> 3
Phe Thr Pro Val Leu Leu Ile Lys Lys Ile Thr Gly Ser His Lys Val
1 5 10 15
Phe Arg Ser Ser Phe Tyr Ser Arg Gly Phe Asn Val Leu Asn Ser Asn
20 25 30
Val Thr Pro Ala Gly Ile Glu Ser Pro Lys Asn Asn Lys Arg Asp Val
35 40 45
Thr Gln Ile Ile Leu Trp Val Tyr Asn Thr Ile Lys Gln Tyr Leu Ile
50 55 60
Lys Ile Leu Thr Phe Ile Phe Gln Lys Glu Leu Gln Thr Glu Asp Thr
65 70 75 80
Ser Ile Lys Lys Asp Ile Gly Lys Gly Asn Ser Asp Gln Glu Ser Asp
85 90 95
Glu Ile Asn Lys Glu Asn Ser Phe Val Glu Cys Asn Met Val Tyr Lys
100 105 110
Ser Lys Asn Leu Leu Thr Asp Tyr Cys Val Asn Arg Phe Pro Ser Glu
115 120 125
Phe Phe Glu Asp Ile Tyr Asn Leu Ser Leu Ser Ala Ile Lys Ser Thr
130 135 140
Tyr Asn Leu Asp Ile Ser Thr Leu Asn Pro Tyr Thr Pro Phe Asp Leu
145 150 155 160
Ser Leu Arg Pro Ser Asp Glu Asp Thr Lys Ile Val Pro Gln Pro Leu
165 170 175
Ile Leu Ser Ile Lys Arg Phe Met Asn Lys Asn Ile Arg Ser Phe Asn
180 185 190
Ser Met Glu Asn Asp Ile Ile Asn Lys Tyr Asn Phe Trp Tyr Glu Ser
195 200 205
Asp Ala Ser His Tyr Ser Asp Leu Asn Gln Lys Gly Ala Leu Ile Asn
210 215 220
Lys Leu Tyr Asn Asn Ser Glu Leu Ala Lys Ser Ile Tyr Gln Asn Leu
225 230 235 240
Thr Asp Ile Glu Thr Thr His Ser Asn Asp Met Leu Lys Asn Ile Val
245 250 255
Gly Glu Asn Ile Glu Gln Glu Ser Asn Glu Ala Asn Ile Lys Arg Phe
260 265 270
Asp Phe Tyr Ser Asn Ile Val Tyr Phe Tyr Tyr Lys Asn Ser Val Lys
275 280 285
Gln Ser Tyr Pro Glu Val Ser Ile Leu Ile Arg Ile Leu Thr Pro Asn
290 295 300
Ile Asn Ser Lys Ile Gly Arg His Pro Lys Val Leu Lys Val Leu Pro
305 310 315 320
Arg
<210> 4
<211> 395
<212> PRT
<213> 微小隐孢子虫(Cryptosporidium parvum)
<400> 4
Leu Lys Val Leu Pro Arg Leu Val Val Ala Ile Glu Ile Leu Cys Val
1 5 10 15
Leu Leu Asn Asn Ser Leu Glu Asp Glu Ile Tyr Asp Phe Arg Ile Ala
20 25 30
Arg Asn Glu Phe Lys Ile Ser Ser Phe Asn Asp Tyr Thr Tyr Asn Gly
35 40 45
Leu Pro Asn Gly Phe Glu Ile His Leu Lys Gly Phe His Asp Val Leu
50 55 60
Pro Lys Phe Leu Arg Ile Phe Ala Lys His Leu Ser His Pro Asn Lys
65 70 75 80
Tyr Phe Thr Leu Glu Gln Phe Glu Asp Ala Phe Lys His Val Asn Arg
85 90 95
Tyr Leu Tyr Gln Tyr Val Tyr Phe Thr Pro Ser Ile Ile Lys Ser Leu
100 105 110
Thr Ile Leu Arg Ser Val Thr Glu Asn Gln Ser Leu Ser Pro Phe Asp
115 120 125
Arg Leu Asn Glu Leu Lys Tyr Ile Ser Tyr Arg Asp Ile Ile Glu Leu
130 135 140
Ser Glu Phe Phe Ala Lys Gln Gly Gln Val Glu Gly Leu Phe Met Asn
145 150 155 160
Asn Ile Asp Pro Phe Glu Ala Gly Leu Val Val Asn Glu Phe Leu Asp
165 170 175
Cys Leu Gly Arg Asn Ile Ile Ile Ser Gly Ile Ile Ser Leu Ser Val
180 185 190
Asn Glu Tyr Asn Ala Glu Ile Val Asp His Glu Leu Leu Lys Asn Ala
195 200 205
Phe Arg Lys Glu Ser Lys Glu Tyr Ser Ile Lys Asn Met Leu Val Pro
210 215 220
Ile Tyr His Ala Gly Glu Asn Tyr Phe Asn Ser Tyr Glu Val Leu Asp
225 230 235 240
Leu Thr Thr Leu Pro Ile Arg Leu Trp Lys Ser Tyr Arg Phe Glu Tyr
245 250 255
Ser Ser Ile Asp Glu Glu Lys Ser Ile Ser Ser Leu Ala Leu Phe Ile
260 265 270
Gly Thr Lys Thr Pro Phe Thr Ile Ser Leu Val Thr Leu Leu Ser Ile
275 280 285
Ile Leu Ser Asp Leu Ala Ser Lys Phe Leu Lys Lys Ile Ser Asn Lys
290 295 300
Asn Tyr Ser Val Val Val Phe Ser Thr Ser Tyr Tyr Ser Thr Leu Thr
305 310 315 320
Phe Ser Val Val Gln Val Glu Ser Tyr Ser Lys Asp Ile Val Ser Leu
325 330 335
Ser Glu Phe Leu Ile Val Phe Ile Lys Glu Ile Phe Glu Thr Pro Phe
340 345 350
Ile Ile Asp Lys Ser Phe Phe Tyr Lys Val Lys Arg Asp Cys Ile Asn
355 360 365
Lys Phe Lys Asn Leu Pro Asn Lys Ile Glu Leu Phe Ser Asn Leu Phe
370 375 380
Phe Thr Phe Ile Glu Gly Thr Asp Phe Pro Phe
385 390 395

Claims (6)

1. 隐孢子虫卵囊壁蛋白,它的氨基酸序列如序列表SEQ ID N0.1、2、3或4所示。
2.根据权利要求1所述的隐孢子虫卵囊壁蛋白,其特征在于:所述的隐孢子虫卵囊壁蛋白位于隐孢子虫卵囊壁外壁的外表面。
3.隐孢子虫特异性多肽,它的氨基序列为:
A-1:C-ENIEQESNEANI
或A-2:KITGSHKVFRSSFYSR-C
或A-3:C-SLSVNEYNAEIVDHE
或A-4:C-NRAYRIDKYVPRGFT;
抗隐孢子虫卵囊壁蛋白抗体,其特征在于:它能与隐孢子虫卵囊壁的外表面特异性结合,所述的隐孢子虫卵囊壁蛋白为权利要求1所述的隐孢子虫卵囊壁蛋白。
4.抗隐孢子虫特异性多肽抗体,其特征在于:它是采用包括权利要求3所述的隐孢子虫特异性多肽的蛋白制备的抗体。
5.抗隐孢子虫卵囊壁蛋白抗体或抗隐孢子虫特异性多肽抗体在检测隐孢子虫的应用。
6.根据权利要求6所述的应用,其特征在于:所述的检测隐孢子虫为检测未破壁的隐孢子虫卵囊。
CN202111323961.2A 2021-11-10 2021-11-10 检测用隐孢子虫卵囊壁外壁标记蛋白质及其应用 Pending CN114031679A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202111323961.2A CN114031679A (zh) 2021-11-10 2021-11-10 检测用隐孢子虫卵囊壁外壁标记蛋白质及其应用

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202111323961.2A CN114031679A (zh) 2021-11-10 2021-11-10 检测用隐孢子虫卵囊壁外壁标记蛋白质及其应用

Publications (1)

Publication Number Publication Date
CN114031679A true CN114031679A (zh) 2022-02-11

Family

ID=80137050

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202111323961.2A Pending CN114031679A (zh) 2021-11-10 2021-11-10 检测用隐孢子虫卵囊壁外壁标记蛋白质及其应用

Country Status (1)

Country Link
CN (1) CN114031679A (zh)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116143875A (zh) * 2022-07-09 2023-05-23 吉林大学 隐孢子虫cgd2_3080卵囊壁外壁标记蛋白质及其应用

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103364569A (zh) * 2013-07-30 2013-10-23 广西壮族自治区兽医研究所 牛隐孢子虫elisa检测试剂盒
US20130330335A1 (en) * 2010-03-23 2013-12-12 Iogenetics, Llc Bioinformatic processes for determination of peptide binding
CN103740733A (zh) * 2014-01-12 2014-04-23 吉林大学 一种诊断用微小隐孢子虫重组抗原
WO2018207760A1 (ja) * 2017-05-09 2018-11-15 国立大学法人京都大学 キナーゼ基質

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130330335A1 (en) * 2010-03-23 2013-12-12 Iogenetics, Llc Bioinformatic processes for determination of peptide binding
CN103364569A (zh) * 2013-07-30 2013-10-23 广西壮族自治区兽医研究所 牛隐孢子虫elisa检测试剂盒
CN103740733A (zh) * 2014-01-12 2014-04-23 吉林大学 一种诊断用微小隐孢子虫重组抗原
WO2018207760A1 (ja) * 2017-05-09 2018-11-15 国立大学法人京都大学 キナーゼ基質

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
ABRAHAMSEN, M.S.等: ""secreted insulinase like peptidase [Cryptosporidium parvum Iowa II]"", 《GENBANK》, pages 626960 *
C WEIR 等: "\"An Immunoglobulin G1 Monoclonal Antibody Highly Specific to the Wall of Cryptosporidium Oocysts\"", vol. 7, no. 5, pages 745 - 750 *
C. WEIR 等: ""An Immunoglobulin G1 Monoclonal Antibody Highly Specific to the Wall of Cryptosporidium Oocysts",", 《CLIN DIAGN LAB IMMUNOL》, vol. 7, no. 5 *
GEORGIA WILK 等: ""Monoclonal Antibodies to Intracellular Stages of Cryptosporidium parvum Define Life Cycle Progression In Vitro"", 《MSPHERE》, vol. 3, no. 3, pages 5 *
彭昊 等: ""安氏隐孢子虫卵囊壁蛋白的原核表达及其免疫原性研究"", vol. 45, no. 10, pages 1870 - 1875 *
武晓东: ""抗微小隐孢子虫卵囊壁单克隆抗体的制备"", no. 8, pages 050 - 372 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116143875A (zh) * 2022-07-09 2023-05-23 吉林大学 隐孢子虫cgd2_3080卵囊壁外壁标记蛋白质及其应用

Similar Documents

Publication Publication Date Title
CA2482334C (en) Method and device for trichomonas detection with adhesin as a marker
CN101023098B (zh) 乙肝病毒s抗原的检测方法
Chatterjee et al. Evidence for mucin-like glycoproteins that tether sporozoites of Cryptosporidium parvum to the inner surface of the oocyst wall
CN109517802B (zh) 分泌鸡白痢沙门菌IpaJ单克隆抗体的杂交瘤细胞株、其单克隆抗体及其应用
Feliziani et al. Immunodominant proteins α-1 giardin and β-giardin are expressed in both assemblages A and B of Giardia lamblia
CN101929999A (zh) 一种用于检测抗膜突蛋白抗体的试剂盒
EP2748612B1 (en) Improved vaccine diagnostics
CN102108355B (zh) 恶性疟原虫的多表位人工抗原及其用途
CN114031679A (zh) 检测用隐孢子虫卵囊壁外壁标记蛋白质及其应用
CN108802368B (zh) 一种酶联免疫检测牛流产衣原体的试剂盒
Ching et al. Recombinant dense granular protein (GRA5) for detection of human toxoplasmosis by Western blot
CN114152748A (zh) 一种检测非洲猪瘟病毒的双抗体夹心elisa诊断试剂盒及其方法
KR101419791B1 (ko) 쯔쯔가무시 균 특이 항체를 검출하기 위한 조성물 및 키트
KR102550527B1 (ko) 흰반점증후군 바이러스에 특이적인 재조합 항체 및 이의 용도
US7741063B2 (en) Toxoplasma gondii oocyst protein
CN111273005B (zh) 一种检测弓形虫IgG抗体的酶联免疫试剂盒及方法
CN115925860A (zh) 隐孢子虫cgd8_1420蛋白质作为卵囊壁外壁标记蛋白质的应用
WO2005124351A2 (en) A sensitive antibody-based method for detecting cryptosporidium parvum oocysts in water
CN106198974A (zh) 一种快速检测虹鳟鱼血清中ihnv抗体的elisa检测试剂盒
Walderich et al. Development of monoclonal antibodies specifically recognizing the cyst stage of Entamoeba histolytica.
CN116143875A (zh) 隐孢子虫cgd2_3080卵囊壁外壁标记蛋白质及其应用
AU2020101749A4 (en) Recombinant protein for rapid detection of Toxoplasma gondii, preparation method and use thereof
CN116143894A (zh) 隐孢子虫cgd2_3320蛋白质作为卵囊壁外壁标记蛋白质的应用
CN116143895A (zh) 隐孢子虫cgd3_4260蛋白质作为卵囊壁外壁标记蛋白质的应用
CN116555291A (zh) 微小隐孢子虫cgd6_660卵囊壁外壁蛋白及其应用

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination